Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trialXiaohua Wu, Mansoor Raza Mirza, Rutie Yin et al.|EClinicalMedicine|2024Cited by 24